BSPM [Biostar Pharmaceuticals,] 8-K: Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to
[Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program NEW YORK and Xianyang, China, The Company’s flagship product is the Xin Ao Xing Oleanolic Acid Capsule, the only SFDA approved OTC drug from the local level to the state level which treats chronic hepatitis B, a condition which affects 10% of the Chinese population. In addition, the]
